financetom
Business
financetom
/
Business
/
Newell's Outdoor & Recreation Segment to Remain 'Weak Point' Heading Into Q2 Earnings, RBC Says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Newell's Outdoor & Recreation Segment to Remain 'Weak Point' Heading Into Q2 Earnings, RBC Says
Jul 24, 2024 11:57 AM

02:44 PM EDT, 07/24/2024 (MT Newswires) -- Newell Brands' ( NWL ) outdoor & recreation segment will likely remain a "weak point" in Q2, as well as the rest of the year, as 2024 ordering is largely complete, RBC Capital Markets said in an earnings preview emailed Wednesday.

The business segment is unlikely to see any real improvement until 2025, limiting the upside on the company's stock, according to the note.

"It remains difficult to get constructive on the stock until we see evidence of abating headwind," RBC said.

RBC also said that despite continued pressure in the company's categories, Newell had a low bar to meet for Q2. The investment firm said it expects the company to post earnings of $0.21 per share on net sales of $2.03 billion.

Any potential outperformance in Q2 and beyond will likely come from Newell's learning & development or home & commercial solutions, RBC said.

RBC has a sector perform rating on the company's stock with a price target of $7.50.

Price: 6.37, Change: +0.06, Percent Change: +0.87

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Quest Diagnostics expands into Canada with nearly $1 bln LifeLabs deal
Quest Diagnostics expands into Canada with nearly $1 bln LifeLabs deal
Jul 3, 2024
July 3 (Reuters) - Quest Diagnostics ( DGX ) said on Wednesday it would acquire Canada-based LifeLabs from pension plan owner OMERS for about C$1.35 billion, or about $985 million, including net debt. LifeLabs, which provides community laboratory tests, would retain its brand, Canadian headquarters and management after the acquisition is closed. The U.S. laboratory operator will acquire 100% of...
Stellantis to Collaborate with France's CEA to Build Next-Generation Battery Cells for EVs
Stellantis to Collaborate with France's CEA to Build Next-Generation Battery Cells for EVs
Jul 3, 2024
09:16 AM EDT, 07/03/2024 (MT Newswires) -- Stellantis NV ( STLA ) said Wednesday it will collaborate with the French research organization CEA over the next five years to design next-generation battery cells for electric vehicles. The joint program includes designing advanced technology cells that provide a higher performance, longer lifespan and lower carbon footprint, Stellantis ( STLA ) said....
Lifeist Wellness Names Andrea Judge As CEO of Mikra Cellular Sciences
Lifeist Wellness Names Andrea Judge As CEO of Mikra Cellular Sciences
Jul 3, 2024
09:18 AM EDT, 07/03/2024 (MT Newswires) -- Lifeist Wellness ( LFSWF ) , a health-tech company trading near 52 week lows, on Wednesday named Andrea Judge as vice president of operations at Lifeist and chief executive officer of Mikra Cellular Sciences, effective immediatly. Judge, who has experience in sales, marketing, and executive management, began her professional career in marketing at...
SeaStar Medical Says US FDA Agrees to Final Labeling for Quelimmune
SeaStar Medical Says US FDA Agrees to Final Labeling for Quelimmune
Jul 3, 2024
09:15 AM EDT, 07/03/2024 (MT Newswires) -- SeaStar Medical Holding ( ICU ) said Wednesday that the US Food and Drug Administration has agreed to the final labeling for its Quelimmune device to treat children with acute kidney injury and sepsis or septic condition requiring kidney replacement therapy. The commercial-stage medical technology company said the final labeling paves the way...
Copyright 2023-2026 - www.financetom.com All Rights Reserved